Residency · Residency · Emergency Medicine
Acute Pancreatitis: Early Management and Fluid Resuscitation
Introduction
Acute pancreatitis is one of the most common gastrointestinal causes of hospital admission, with approximately 300,000 cases annually in the United States. The disease ranges from mild, self-limited interstitial edematous pancreatitis, which accounts for 80% of cases, to severe necrotizing pancreatitis with multi-organ failure and mortality rates exceeding 30%. Early aggressive management in the ED, particularly fluid resuscitation, pain control, and identification of complications, drives outcomes.
Etiology
Common Causes (Mnemonic: I GET SMASHED)
The mnemonic I GET SMASHED covers the major etiologies. Idiopathic causes account for 15 to 25% of cases. Gallstones are the most common cause at 40%, with biliary sludge also being causative. Ethanol and alcohol represent the second most common cause at 25 to 35% and typically require years of heavy use. Trauma includes blunt abdominal injury and post-ERCP pancreatitis, which occurs in 3 to 5% of ERCP procedures. Steroids and other medications can trigger pancreatitis. Mumps and other infections such as Coxsackie, CMV, and HIV are recognized causes. Autoimmune pancreatitis is an IgG4-related disease. Scorpion stings from Tityus species are more relevant in tropical regions. Hyperlipidemia with triglycerides greater than 1000 mg/dL and hypercalcemia are metabolic causes. ERCP is the most common iatrogenic cause. Specific drugs implicated include azathioprine, valproic acid, didanosine, GLP-1 receptor agonists, and thiazides.
Diagnosis
Clinical Presentation
The hallmark is epigastric pain radiating to the back, with sudden onset, severe and constant character, worsening when supine and improving when leaning forward. Nausea and vomiting occur in 90% of patients. Abdominal tenderness with guarding is typical, and distension from ileus may be present. Tachycardia and hypotension occur in severe cases due to third-spacing of fluid. Cullen sign, periumbilical ecchymosis, and Grey Turner sign, flank ecchymosis, are rare but indicate hemorrhagic pancreatitis with retroperitoneal bleeding.
Diagnostic Criteria (Revised Atlanta Classification)
Diagnosis requires two of three criteria: characteristic abdominal pain (acute onset, severe, epigastric), serum lipase at least three times the upper limit of normal (lipase is more sensitive and specific than amylase, and amylase can be normal in alcohol-induced and hypertriglyceridemic pancreatitis), and characteristic findings on imaging (CT, MRI, or ultrasound).
Laboratory Evaluation
Lipase is the preferred biomarker and remains elevated longer than amylase (8 to 14 days versus 3 to 5 days). CBC may show leukocytosis, and hemoconcentration with elevated hematocrit is a marker of severity. BMP should be assessed because BUN elevation correlates with severity and mortality, and creatinine should be monitored for acute kidney injury. An ALT greater than 150 IU/L has a positive predictive value exceeding 85% for gallstone pancreatitis. Triglycerides should be checked if no gallstones or alcohol history are present, as levels above 1000 mg/dL are causative. Hypocalcemia indicates severe disease due to calcium sequestration in fat necrosis. Lactate and arterial blood gas assessment are useful for evaluating end-organ dysfunction and metabolic acidosis in severe cases.
Imaging
Right upper quadrant ultrasound should be obtained in all patients to evaluate for gallstones and biliary dilation, as this determines the need for ERCP or cholecystectomy. CT abdomen with IV contrast is not routinely indicated in the ED for diagnosis and is most useful 48 to 72 hours after symptom onset to assess for necrosis and complications. MRCP is superior for detecting choledocholithiasis and is used when a bile duct stone is suspected but not confirmed on ultrasound.
<image>Contrast-enhanced CT scan of severe acute pancreatitis showing peripancreatic fluid collections, areas of pancreatic necrosis with lack of enhancement, and annotations identifying the pancreatic head, body, and tail with areas of inflammation highlighted</image>
Severity Assessment
BISAP Score (Bedside Index of Severity in Acute Pancreatitis)
The BISAP score is calculated within the first 24 hours using data available in the ED. It includes BUN greater than 25 mg/dL, impaired mental status (GCS less than 15), SIRS criteria (two or more of: temperature greater than 38 degrees Celsius or less than 36 degrees Celsius, heart rate greater than 90, respiratory rate greater than 20, WBC greater than 12,000 or less than 4,000), age greater than 60, and pleural effusion on imaging. A score of 3 or higher indicates severe pancreatitis with significantly increased mortality of 5 to 22%.
Revised Atlanta Classification -- Severity Grading
| Severity (Revised Atlanta) | Organ Failure | Local Complications | Proportion | Mortality |
|---|---|---|---|---|
| Mild | None | None | 80% | < 1% |
| Moderately severe | Transient (< 48 hrs) | May be present | 15% | < 5% |
| Severe | Persistent (> 48 hrs) | Often present | 5% | 15–30% |
Mild pancreatitis involves no organ failure and no local complications, accounts for 80% of cases, and carries mortality less than 1%. Moderately severe pancreatitis involves transient organ failure lasting less than 48 hours or local complications. Severe pancreatitis involves persistent organ failure lasting more than 48 hours and carries mortality of 15 to 30%.
Other Prognostic Markers
A hematocrit greater than 44% at admission suggests hemoconcentration and predicts severe disease. BUN elevation and failure to decrease with resuscitation is an independent mortality predictor. CRP greater than 150 mg/L at 48 hours correlates with necrotizing pancreatitis. Ranson criteria, calculated at 0 and 48 hours, and APACHE II remain valid but are cumbersome for ED use.
Fluid Resuscitation
Rationale
Acute pancreatitis causes massive third-spacing of fluid into the retroperitoneum and peritoneal cavity. Hypovolemia leads to pancreatic microcirculatory failure, worsening necrosis. Early aggressive fluid resuscitation has been the traditional approach, but recent evidence supports a more moderate strategy.
Current Evidence and Approach
The WATERFALL Trial published in 2022 compared aggressive fluids (20 mL/kg bolus plus 3 mL/kg per hour) versus moderate fluids (1.5 mL/kg per hour with a bolus only if hypovolemic) and found that aggressive fluids increased fluid overload without improving outcomes. The recommended approach is now goal-directed, moderate fluid resuscitation. Lactated Ringer's is preferred over normal saline due to its anti-inflammatory properties and lower risk of hyperchloremic acidosis. The initial rate should be 1.5 mL/kg per hour with reassessment every 6 hours. Boluses of 20 mL/kg should be reserved for patients with hemodynamic compromise or clinical evidence of hypovolemia. Targets include urine output of 0.5 to 1 mL/kg per hour, improving BUN, heart rate less than 120, and MAP greater than 65. Overhydration should be avoided because it increases the risk of abdominal compartment syndrome and respiratory failure without reducing necrosis.
<image>Fluid resuscitation strategy diagram for acute pancreatitis comparing traditional aggressive approach versus modern goal-directed approach, showing decision points based on hemodynamic assessment, target urine output, BUN trends, and warning signs of fluid overload</image>
Pain Management
Pain in acute pancreatitis is severe, and undertreated pain increases sympathetic tone, splanchnic vasoconstriction, and patient distress. Opioids such as hydromorphone or fentanyl are appropriate, and the historical concern that morphine causes sphincter of Oddi spasm is not supported by clinical evidence. Multimodal analgesia should include acetaminophen, NSAIDs such as ketorolac 15 to 30 mg IV if there are no contraindications, and opioids. Patient-controlled analgesia is effective for inpatient management. Epidural analgesia may benefit patients with severe pancreatitis requiring ICU admission.
Nutrition
Early oral feeding within 24 hours with a low-fat solid diet as tolerated is now recommended over prolonged NPO status. NPO should be reserved for intractable vomiting, ileus, or planned early intervention such as ERCP. Enteral nutrition via nasojejunal tube is preferred over parenteral nutrition in severe pancreatitis when oral intake is not possible, as it maintains the gut barrier and reduces infection.
Management of Specific Causes
Gallstone Pancreatitis
ERCP within 24 hours is indicated for concurrent cholangitis or persistent biliary obstruction with rising bilirubin and dilated common bile duct. ERCP is not indicated for gallstone pancreatitis without cholangitis or obstruction. Cholecystectomy should be performed during the same admission for mild gallstone pancreatitis to prevent recurrence, which occurs in up to 30% of patients when surgery is delayed.
Hypertriglyceridemic Pancreatitis
Insulin infusion at 0.1 to 0.3 units/kg per hour with dextrose activates lipoprotein lipase, reducing triglycerides. Plasmapheresis is reserved for refractory, severe hypertriglyceridemia with triglycerides above 2000 mg/dL and organ failure. Fibrates and dietary modification are used for long-term management.
Complications
Peripancreatic fluid collections occur early and most resolve spontaneously. Pancreatic pseudocysts develop after more than 4 weeks and are encapsulated collections without necrosis. Walled-off necrosis develops after more than 4 weeks and represents an encapsulated necrotic collection that may require drainage if infected. Infected necrosis should be suspected if clinical deterioration occurs after initial improvement; CT-guided fine needle aspiration for culture confirms the diagnosis, and treatment involves carbapenems such as meropenem and minimally invasive drainage. Abdominal compartment syndrome is diagnosed by bladder pressure greater than 20 mmHg with organ dysfunction and requires decompression. Organ failure including ARDS, AKI, DIC, and cardiovascular collapse may develop.
<image>Timeline illustration of acute pancreatitis complications showing early phase (first 2 weeks) with SIRS, organ failure, and peripancreatic fluid collections versus late phase (after 2 weeks) with infected necrosis, pseudocyst formation, and walled-off necrosis with management considerations at each stage</image>
Clinical Pearls
Lipase alone is sufficient for diagnosis, and there is no added value in ordering both lipase and amylase; the degree of lipase elevation does not predict severity. A right upper quadrant ultrasound should be obtained in all patients with pancreatitis to evaluate for gallstones, and an ALT greater than 150 IU/L strongly suggests a biliary etiology. The WATERFALL trial has shifted practice away from aggressive fluid resuscitation toward goal-directed, moderate fluids with lactated Ringer's at 1.5 mL/kg per hour, reserving boluses for hypovolemia. Early oral feeding as tolerated is superior to prolonged NPO status. CT should generally be deferred until 48 to 72 hours after onset unless an alternative diagnosis such as perforation or mesenteric ischemia is being considered.
References
- de-Madaria E, et al. "Aggressive or Moderate Fluid Resuscitation in Acute Pancreatitis (WATERFALL Trial)." New England Journal of Medicine. 2022;387(11):989-1000.
- Banks PA, et al. "Classification of Acute Pancreatitis -- 2012: Revision of the Atlanta Classification." Gut. 2013;62(1):102-111.
- Crockett SD, et al. "American Gastroenterological Association Institute Guideline on Initial Management of Acute Pancreatitis." Gastroenterology. 2018;154(4):1096-1101.
- Tenner S, et al. "American College of Gastroenterology Guideline: Management of Acute Pancreatitis." American Journal of Gastroenterology. 2013;108(9):1400-1415.
